LAST PRICE - AT THE CLOSE
DRUG is UP 2371% since the begininning of the year
DRUG is DOWN -20% BELOW 20 day SMA
DRUG is UP 395% ABOVE 200 day SMA
PROFITABLE: YES
EPS: $0.0376
EARNINGS MOMENTUM: N/A
N/A INCREASE IN QTRLY EARNINGS
P/E RATIO IS: N/A
INCOME TO DEBT RATIO: 0.00
 |
THE STOCK IS 55.3% AWAY FROM ALL-TIME HIGHS OF $79.02 |
 |
DRUG IS UP 2371% SINCE THE BEGINNING OF THE YEAR |
 |
DRUG IS UP 2434% OVER THE PAST 12 MONTHS |
 |
DRUG IS DOWN -29% OVER THE PAST 1 MONTH |
 |
12% OF ALL DRUG INVESTORS ARE BETTING AGAINST DRUG |
 |
NUM INVESTORS SHORT DRUG HAS GONE UP N/A% VERSUS LAST MONTH |
| Type | Description | Time |
|---|
 |
DRUG moved down 1.39 in the previous minute |
 |
DRUG is up 1.39 over the last hour |
 |
DRUG is up 17.4% over the last 5 days |
 |
DRUG is 6.3 above its 8 day SMA |
| $31.35 |   DAY |
$36.72 |
| $30.67 | PREVIOUS DAY |
$33.33 |
| $30.67 |  WEEK |
$43.29 |
| $30.67 | MONTH |
$58.00 |
| $0.93 | YEAR |
$79.02 |
DRUG is mentioned N/A less than normal on 
DRUG is mentioned N/A times in an average day on 
